These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26294282)

  • 21. Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons.
    Caleo M; Spinelli M; Colosimo F; Matak I; Rossetto O; Lackovic Z; Restani L
    J Neurosci; 2018 Nov; 38(48):10329-10337. PubMed ID: 30315128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography.
    Kumaran D; Adler M; Levit M; Krebs M; Sweeney R; Swaminathan S
    Bioorg Med Chem; 2015 Nov; 23(22):7264-73. PubMed ID: 26522088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clostridium botulinum and botulinum neurotoxin].
    Hirai Y
    Brain Nerve; 2011 Jul; 63(7):755-61. PubMed ID: 21747146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B.
    Wang J; Zurawski TH; Bodeker MO; Meng J; Boddul S; Aoki KR; Dolly JO
    Biochem J; 2012 May; 444(1):59-67. PubMed ID: 22360156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons.
    Dong M; Tepp WH; Liu H; Johnson EA; Chapman ER
    J Cell Biol; 2007 Dec; 179(7):1511-22. PubMed ID: 18158333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation of synaptotagmin as a receptor for types A and E botulinum neurotoxin and analysis of their comparative binding using a new microtiter plate assay.
    Li L; Singh BR
    J Nat Toxins; 1998 Oct; 7(3):215-26. PubMed ID: 9783260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells.
    Dong M; Richards DA; Goodnough MC; Tepp WH; Johnson EA; Chapman ER
    J Cell Biol; 2003 Sep; 162(7):1293-303. PubMed ID: 14504267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes.
    Fischer A; Montal M
    Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10447-52. PubMed ID: 17563359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.
    Jin R; Rummel A; Binz T; Brunger AT
    Nature; 2006 Dec; 444(7122):1092-5. PubMed ID: 17167421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin.
    Edupuganti OP; Ovsepian SV; Wang J; Zurawski TH; Schmidt JJ; Smith L; Lawrence GW; Dolly JO
    FEBS J; 2012 Jul; 279(14):2555-67. PubMed ID: 22607388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis of cell surface receptor recognition by botulinum neurotoxin B.
    Chai Q; Arndt JW; Dong M; Tepp WH; Johnson EA; Chapman ER; Stevens RC
    Nature; 2006 Dec; 444(7122):1096-100. PubMed ID: 17167418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum neurotoxins A, B, C, E, and F preferentially enter cultured human motor neurons compared to other cultured human neuronal populations.
    Pellett S; Tepp WH; Johnson EA
    FEBS Lett; 2019 Sep; 593(18):2675-2685. PubMed ID: 31240706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mastoparan-7 rescues botulinum toxin-A poisoned neurons in a mouse spinal cord cell culture model.
    Zhang P; Ray R; Singh BR; Ray P
    Toxicon; 2013 Dec; 76():37-43. PubMed ID: 24047963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum neurotoxin A and an engineered derivate targeted secretion inhibitor (TSI) A enter cells via different vesicular compartments.
    Fonfria E; Donald S; Cadd VA
    J Recept Signal Transduct Res; 2016; 36(1):79-88. PubMed ID: 26329879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative role of neurotoxin-associated proteins in the structural stability and endopeptidase activity of botulinum neurotoxin complex types A and E.
    Kukreja RV; Singh BR
    Biochemistry; 2007 Dec; 46(49):14316-24. PubMed ID: 18004882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
    Sharma SK; Singh BR
    Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atoxic derivative of botulinum neurotoxin A as a prototype molecular vehicle for targeted delivery to the neuronal cytoplasm.
    Vazquez-Cintron EJ; Vakulenko M; Band PA; Stanker LH; Johnson EA; Ichtchenko K
    PLoS One; 2014; 9(1):e85517. PubMed ID: 24465585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An efficient drug delivery vehicle for botulism countermeasure.
    Zhang P; Ray R; Singh BR; Li D; Adler M; Ray P
    BMC Pharmacol; 2009 Oct; 9():12. PubMed ID: 19860869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibiting oral intoxication of botulinum neurotoxin A complex by carbohydrate receptor mimics.
    Lee K; Lam KH; Kruel AM; Mahrhold S; Perry K; Cheng LW; Rummel A; Jin R
    Toxicon; 2015 Dec; 107(Pt A):43-9. PubMed ID: 26272706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type A botulinum neurotoxin complex proteins differentially modulate host response of neuronal cells.
    Wang L; Sun Y; Yang W; Lindo P; Singh BR
    Toxicon; 2014 May; 82():52-60. PubMed ID: 24560879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.